PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9
PROPHASE LABS INC. TO PRESENT FIRST QUARTER 2024 FINANCIAL RESULTS ON MAY 9
GARDEN CITY, NY, May 02, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be presenting first quarter 2024 financial results on a virtual conference call hosted by Renmark Financial on May 9, 2024 at 11:00 am EDT. A press release detailing these results will be issued prior to the virtual conference call. ProPhase Labs Inc. welcomes stakeholders, investors, and other individual followers to register and attend this live event.
纽约州花园城，2024年5月2日（环球新闻专线）——ProPhase Labs Inc.（纳斯达克股票代码：PRPH）今天宣布，他们将在美国东部时间2024年5月9日上午11点由Renmark Financial主办的虚拟电话会议上公布2024年第一季度财务业绩。将在虚拟电话会议之前发布详细介绍这些结果的新闻稿。ProPhase Labs Inc. 欢迎利益相关者、投资者和其他个人关注者注册并参加本次直播活动。
Investors interested in participating in this live event will need to register using the link below. After the event, a replay will be available on The Company's Investor website.
有兴趣参加本次直播活动的投资者需要使用以下链接进行注册。活动结束后，将在公司的投资者网站上提供重播。
REGISTER HERE:
在这里注册：
-
To ensure smooth connectivity, please access this link using the latest version of Google Chrome.
- 为确保顺畅连接，请使用最新版本的 Google Chrome 访问此链接。
About ProPhase Labs Inc.
ProPhase Labs, Inc. (NASDAQ: PRPH) is revolutionizing healthcare through innovative solutions in biopharma, genomics, diagnostics, and therapeutics. With a commitment to advancing personalized medicine and improving patient care, ProPhase Labs is at the forefront of technological advancements in the healthcare industry. For more information, visit
关于 ProPhase Labs Inc.
ProPhase Labs, Inc.（纳斯达克股票代码：PRPH）正在通过生物制药、基因组学、诊断和治疗方面的创新解决方案，彻底改变医疗保健。ProPhase Labs致力于推进个性化医疗和改善患者护理，处于医疗保健行业技术进步的最前沿。欲了解更多信息，请访问
ProPhase Media Relations and Institutional Investor Contact:
ProPhase Labs, Inc.
267-880-1111
investorrelations@prophaselabs.com
ProPhase 媒体关系和机构投资者联系方式：
ProPhase Labs, Inc.
267-880-1111
investorrelations@prophaselabs.com
ProPhase Retail Investor Relations Contact:
Renmark Financial Communications
John Boidman:
514-939-3989
jboidman@renmarkfinancial.com
ProPhase 散户投资者关系联系人：
伦马克金融通讯
约翰·博伊德曼：
514-939-3989
jboidman@renmarkfinancial.com
Source: ProPhase Labs, Inc.
资料来源：ProPhase Labs, Inc.
译文内容由第三方软件翻译。